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06factres. This study was designed to assess the clinical,
hemldyeamk sad dbgaodle elhets of the addittia ofdobutamine
to d1pyridri ochoardlegraphy .
Baetgreaad. PYmnmtdegie stress ebaardlegraphy with eI-
Om dtpyridamvte or dot ahmine ban gird acceptance beement
otib sally, 0ualbglpy, dhgaootkaeeuraey and prognostcpower.
The main Imitation of the Iwo asset is a less time Ideal sensitivity
hsomepatatushorh,state usphew with Ihwlted coronary artery
diem. We hype thus two phmmmbgie sheets might
act naer tally h the induction of ischemin by combining the
mxYnisma of inappropriate coronary vasedialon (with dlpyr.
Wmak) and m bananas In myocardial oxygen cmsumptem (with
Mathado. One hundred My patents (men I3SDI age 51 :t I l
years) strsed her sham edaeardlography wen Initially studied
by O~prkamh-dtbetamha «hoardiography.
The Net was
ahpped during Ire dlpyrtdamok step In 95 pusleab for achieve-
must of a predetermined ad pit (obvious dyasynergy In.
duced by lessor or higher dipyridamoe dual, and dipyrldamole.
dobusadna lob wore performed in 55 patients (segatve dipyr,
hhmak odeeandkpapYe hat) . In the seem 150 patients the
dehehdne eeraeadkgepbk her (up to 40 mop body weight
per met) wen pefmmed on a separate day .
Result. SigiHad summary artery disease (>50% diameter
Dipyridmnole and dobutamine echocardiographic tests have
both proved effective for noninvasive diagnosis of coronary
artery disease (1-6) . The diagnostic accuracy of both tests is
excellent and comparable (7) : nevertheless . as with all
known noninvasive tests, the sensitivity may be less than
ideal in certain patient subsets,
such as those with single-
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stenods of at had on major coronary vessel by quantitative
coronary arteriaaraphy) was present to 131 pad" (ON
vessel In
115; two vessels In 10, three vessels In 6), with normal coronary
arterlography In 19. The Raslbility of the dipyridamole-
dohuhmine test was 96% . Selfaimalng side
el6ets occaered In
5% of patients . The peak ate-peemare product
was
lowest during
the dipyridamole test (132 t 30) and was comparable during the
dobohmiee (186 A 59) and dipyrilamole-dohutamine teals (179
:b
45, p = NS vs
. dubuhnlue; p < 0.01 vs. dipyrldamle). Sed-
tivig was 71% for dlpyrWmok,
75% fer dobudamine mull
92% for dlpyridmala4ohofantim eeboeurdiography (dipyrtda-
mole vs. dlp)ridmohdobatamim, p < 0.01; dabutamine vs
,dipyridamolrdoiwWmhe, p < 0.01; dipyrkhnele vs, dobn-
lambse, p = Nit), waerms specificity was 89% for dipyridamole,
79% for dobuhlie ad 89% for dipyridmndedobutanhe
echocmdiograppy (p =
NS
for all).
Conclusion,. Routine dehummlne addition to dipyridesale
stress tssteg is clkblly uwSel and well tolerated. It
expands the
spectrum of the disease detectable by pharmacobgle
stress echo-
cardiography and allows deamentedan of milder forms of care-
nary artery dham that ® be aniseed by usawad9nal dipyrl-
danole or dirhdm street Khmemulkwastisr
.
(J Am Call
Cordial
1994;23:1115-22)
vessel coronary artery disease or evaluated during antiangi-
nal therapy
(7-12)
.
A theoretically attractive way of increasing pharmaco-
logic stress cchocatdiographic sensitivity would be the com .
bination in a single stress test of dipyridamole
and dobu-
tamine. They act through different and potentially synergic
mechanisms because dipyridamole reduces subendocardial
supply through flow maldistnbution phenomena, whereas
dobutamine increases myocardial oxygen demand through
increase in heart rate and contractility (13). Furthermore, in
the presence of a maximally dilated coronary bed, perfusion
is critically dependent on the duration of diastole (14), so
that addition of a chronotropic stress to dipyridamole should
also lead to a reduction in oxygen supply . However, to our
0735.1097194557 .93
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knowledge a combined dipyridamoledobummim stress test
has not been tried before. presumcily because of concern
that combining these two potent cardiovascular drugs in
doses four to six limes higher than therapeutic ones may
result in serious side efecis . We therefore performed dipyr-
idamole
echocardiography
in consecutive patients scheduled
to undergo coronary aogiography ; In those patients with a
negative test, it was repeated with dobutamine added . The
feasibility, safety and diagnostic accuracy of the combined
dipyridamdedabutamine echocardiographic lest were then
assessed. Our working hypotheses were the 1) a combined
dipyrldamoledobutnmloe echocardlographic stress teat
would be sell: and feasible ; end 2) contllned dipyridamole
and dobuicmine would have a synergistic action In provok .
ins mymearaial iachemia .
Methods
Study gadNns. Patients with a history of ether typical or
atypical effort pain, with or without previous myocardial
infarction, were Initially considered . Patients with unsanble
angina, cardiac failure, severe congenital or valvular been
disease, conduction disturbances or documented cardi0my-
apathy were excluded from tine study . Patients with sevens
hypertension (systolic pressure X200 mm Hg, diastolic pres-
sure >120 mm Hg) and recent muligimas ventricular arhyth-
miss were also excluded because these omdittions represent
a contraindication to dobutamine stress . Patients with severe
asthmatic disease requiring long-term therapy with oral
phyllines were excluded as well because dipyridamole suns
is ineffective in this situation (phyllirie blocks the adenosine
receptors). All patients with previous myocardial Infarction
wore studied at least 4 weeks after the sent- event . An initial
group of 150 patients (mean [±SD] age 51 ± I I years) were
evaluated and underwent dipyridamok echocardiogiaphic
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tenting. Of these, 95 partners had a positive test and were
excluded from further combined testing, The ramainiog 55
patients (45 men, t0 women, mean age 50 2:12 years, rang
28 to 71) had a negative dipyridaumk echaeardiopaphic tat
and underwent combined dipyeidamole •d obntamine echo-
cardiagtaphie testing on the following day. The same Initial
set of 150 patients alw had a dobuumine echocardlographic
test oi. a separate day but within 3 days of the dipyridamole
and dipyridamole-dobutamine eehocardiographic tests .
Moat patients had eoGang(vl therapy as the then of went
testing (Table 1). Dlsttlbmion of dinial forms of coronary
artery disease in the 150 patients was Q wave myocardial
inftaalon h 38 (25%), nms.Q wave myocerdhd h$relion in 38
(25%), mdna in 79 (39%) and Mypksl chest paid in 15 (10%) .
D(pytliamdle
was to,
Dipytidam
old
was Infused at a
rate of 036 mg/kg body weight for 4 min, followed by 4 min
of m dose add then 0.23 esg/kg in 2 min. The cumulative
dose was therefore 0.84 mg/kg for 10 min.
Dobutarie stress to . Dobutemine was infused by
means of a mechanical pump, atoning at a dose of 5
4kg
per min for 3 min.
progressing
to 10 pplkg per min for 3 dirt
and then increasing ht 3-mis Intervals w 20,30 and 40
jug/kg
per min, except for the lass 9°m of 40 pglkg per mid, which
hod for 5 min .
Diysldsaele'dahalmWe arm tat, Dipyridamole was
given
with
the usual Infusion protocol (up to 0 .84 mg/hg
in 10 min). At the end of the infusion, dobutamine infusion
was started with tine usual protocol up to 40 pkkg per min
(Pig. 1). Amieighylline ad proprenolol were available .
Aminophylline (40 to 70 mg fort min) was always given, in
negative tests as well, at the fifth mitre from the end of
dobutamise administration
.
Ted mdbodaklgy . After routine preparation for stress
testing and insertion of an hbtmvenous line, rest electrocar
diopaphy ad
two-dimensional
echocardiography were per-
DET+
(n-951
DIPWB
(n=551
p
Val
e
51!10 So t13 NS
8)15
4.3110
NS
33114%)
101118) NS
24 42303 1412581 NS
37 (39%) 22)40(4) NS
60%) 9110) NS
41190 1 31160%) r 0.601
5158) 711301 Ms
r {9581 4s (5756) Ns
37(39%) 25(47%) NS
3914181
17(318) PlO
71675%) 33160%) 049
6(la) 501 NS
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Figere 1 . Protocol of the dipyridamolc dobutamine WA . ECU =
c ectraardiogram: ECHO = echocardiography .
farmed. During the procedure, blood pressure and an ekc-
trocardiogtem (ECG) were recorded each minute . Two-
dimemiorel
echocardiograms
were obtained continuously
and intermittently recorded and digitized at the start of the
study, at the end of each stage and at the conclusion of stress
testing. Commercially available imaging systems (Hewlet-
Packard 77020 and Sooos 1500 . Toshiba Sonoloyer
FFA270A, Esacte Biomedica SIM 7000 or Diasonics 12 .5-
and 3 .5-MHz transducers]) were used . In the baseline stud-
ies as well as duping stress, all standard echocardiogmphic
views wear' obtained whenever possible . During the lost
.
new
at_" dabnormal wall motion were identified in multi-
ple views whenever possible . The videotapes were analyzed
by the cardiologist-echocatdiographer perfuming the study .
who was unaware of the clinical and engiographic data A
digital acquisition of images of interest was performed, and a
side by side display of rest and peak stress images in a
doe-loop mode was obtained, Positivity of the test was
based on the detection of transient dyssyoetpy of wnlrac
Lion, which was absent or of a lesser degree in the baseline
examination
. Only eehoeardiographle criteria (a new or
worsening wall motion abnormality) were considered as
positive tests. Neither the presence of a rest welt motion
abnormality nor the presence of stress-induced angina or
ischemie ECO changes were considered positive test results .
A high level l>90Y) of interobsetver and intraobaerver
reproducibility of stress echocardiography readings in our
labtnatory among experienced observers has previously
been shown (15) . A wall met= score i dew was derived for
rest and peak stress echocardiograms in each patient by
consensus between the two observers . The left ventricle was
divided Into 11 segments: apex: proximal and dislel septum
:
proximal and distal inferior septum ; proximal and distal
anterior wall
; proximal and distal lateral wall ; proximal and
distal inferior wall, Segmental wall motion was graded as
'ollows
: I (normal) = normal motion at rest, with normall
increased wall motion (hyperkinesial after stress ; 2 (hypok-
ioetic) = marked reduction of endocardial motion : 3 (aki.set-
ic) = virtual absence of inward motion
; 4 (dyskinetic) =
pamdoxic wall motion away from the left ventricular center
OSTOJSC ET AL . 1117
DIPYRIOAMOLE.UOEV-rAMINE STRESS ECHOCARDIOGRAPHY
in systole . The wail motion score index was derived by
summation of individual segment scares divided by the
number of interpreted segments . Inadequately visualized
segments were not seemed, Fnd paints of the test were the
achicvcmcnt of peak dose, development of obvious echuesr-
diographic positivity . severe angina. diagnostic (>0.2-mV ST
segment depression) ECG positivity or the occurrence of
severe, limiting side effects . These included hypertension
(systolic pressure >770 mm Hg, diastolic pressure
>120 mm Hg) . hypotension (>20-mg Hg decrease in systolic
pressure)
. bradycaedia, dyspnea or complex arrhythmias
(atrial fibrillation or supraventricular tachycardia ; frequent,
polymolphuus or repetitive ventricular premature beats
alone or in combination) .
Angiographie study. Patients underwent single-plant left
ventriculography and selective right and left coronary arse
.
riography using either the ludkins or Suites technique.
Multiple views of each coronary artery were obtained,
including cruniocaudal views. After visual inspection of the
coronary arteries in all views, the ftwue in which the most
severe lemon appeared was selected and analyzed . after
off-lire digiriratum, by an array processor-based computer
for medical image processing (Mipron . Kontroa or MEDIS).
Coronary artery disease was considered present if the diam-
eter of at least one major coronary artery was narrowed
?50h with respect to presteuocic tract . An experienced
observer, unaware of the results of the noninvasive tests .
analyzed the coronary aagiograms.
Statistical
analysts.
Data are expressed as mean value '_
SD . Comparisons between groups for continuous data were
made with the Student t test. Sensitivity and specificity in
detecting angiopaphically assessed coronary artery disease
were calculated according to standard definitions . Differ-
ences between the results of the dipyridamole, dobutantine
and dipyridamole-0obutamine echocardiographic tests were
compared by means of the chi-square test; a Fisher exact
test was used when appropriate . Differences between groups
with regard to minimal lumen diameter and percent of
diameter steuosis were analyzed by analysis of variance
. A
probability value of p < 0
.05 was accepted as statistically
significant .
Iffegults
A total of 150 patients were considered for analysis . All
patients had a dipyridamole echocardiographic test and, 'in a
separate dny, a dobutamine echocardiagraphic test . Those
patients with a negative dipyridamole echocardiugraphic test
progressed I, combined dipyridamole-dobutantine echocar-
diographic testing .
Anglographle findings. In 131 of ISO patients significant
coronary artery disease was present
: one vessel in 115 (left
anterior descending coronary artery in 76 [proximal in 46,
medial in 30], left circumflex coronary artery in 17 . right
coronary artery in 22) . two vessel in 10 and three vessel in 6 .
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In 19 patients no coronary lesions were documented by
Cosoaary
,
angiograaphy.
Uipysldamole ahsardlegraphk Nat Indigo. The dipyr-
idamole echocardiographic test was well tolerated in Jdl
patients (Table 2). Overall sensitivity and specificity for
coronary artery disease were 71% (95% confidence interval
ICI] 63% to 79%) and 89% (95% Cl 76% to I00%) (Fig. 2
and 3).
Dobutemlne uroerdisgrephle had fhsBogo. The dobu-
tamine echocardiographic test could be completed m 98% of
patients
. In 2% of patients, limiting side effects precluded the
achievement of a predetermined end point (Table 2). Overall
sensitivity and specificity for memory artery disease were
75% (95% Cl 67%
to 82%) and 79% (95% CI 61% to 97%, p
NS vs. dipyridamae echoardiographic test) (Fag. 2 and 3).
Nine patients with coronary artery disease and a positive
dipyridamole study had a negative dobutamine study,
whereas 14 patients with coronary artery disease and a
negative dipyridamale study had a positive dobutamine
study Conversely. of the Four patients with no coronary
artery disease who had a "false positive" dobmamine study,
one also had a positive dipyridamole study. Of the two
Pew
2. Bar graph showing sensitivity of dipyddamok (DE).
dobutamine (DOBET) and dipyridamok-dohutamise (DIPDOB)
echocardiography. The latter provide a clear step up k sensitivity
versus the other two tons. Sensitivity ordlpyridamula'dohetandoe
echucardiaeraphy was calculated as cumulative, considering It as a
single test with two stages.
sensitivity (%) ' pe0.01
patients with no coronary artery disease who had a "false
positive" dipyridanmle study . one also had a positive dob-
ulamine study.
The overall concordance between dipyridamole and dob-
atamine stress ecbocardiogtaphie results concerning positiv-
tty or
negativity was 8E%
. Good agreement was observed
with regard to the extent and severity of stress-induced
dyssynergy
. In fact, there was a significant correlation
between the peak dipyridamole and peak dobulandines wall
motion score indexes (r - 0.71, p < 0.01).
Fate y and soft
. Interpretable images were ob-
tained in all dipyridamole-dobutamine studies . In two pa-
tients the peak dipyridamde-dobmandes: dose was not com-
pleted despite echocardiography negativity for limiting aide
effects (vomiting in one patient at 20
pa/kg
per min, symp-
tomatic hyposamion in one patient at 20 pp/kg per min) . Of
these two patients notes had significant coronary artery
disease . In one patient severe hypertension occurred at
5 ,vg/kg per min, and that patient had a true positive result .
In 35 patients (64%) . some side efipets occurred during
dipyridamoledobummine stress (chilling tremor in 31%,
prepmtule ventricular contractions in 13%, headache in
20%, nausea in 9%, flush oo in 7%, dyspnea in 2%) . In 20
lifers 3
. Bar graph shows that
specificity
is simian in the three
mean dipyrid •n
de (DIM
. dohukmau (DOW and dipydisrdo-
daps usi s MIPDOB)ecMunlispaphy . Spedialgyddipydda ndr
dabstn I echssasdispaphy was calculated as cansidmay it m a
single test with two stapes.
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patients (36%), dipyridamole-dobummine tests were accom-
plished without any side effects. The overall feasibility (that
is, P-hieveotem of peak dose or target heart raw or echocar-
apbic positivity) of the dipyridamole-dobsmmine test
was 96% (p = NS vs
. dipyridamole lest . 10000, and vs.
dnbutmnine rest, 98%)
. In 27 patients with eehueardiugaphy
positivity for ischentia and in 10 patients with side effects,
signs of ischemia or side effects, or both . were promptly
reversed by stopping the dobummine infusion and amino-
phyllinc injection. No patients received intravenous pro-
prano)ol.
Hemodyoamlc mss. Changes in heart rate, blood
pressure and rate-pressure product with dipyridamole alone
.
dobutamine aim and combined dipyridattmle-dobummiae
are shown in Table 2. Peak heart rote during the dipyridamole-
dobutemine test was similar to that observed with dobu-
mmine alone and significantly higher than with dipyridamele
alone, Peak systolic and diastolic blood pressures were
significantly lower during dipyridaowle-dobutamine tests
than during debutamine alone (p < 0.01 and p < 0
.05.
respectively). Heart rate-pressure product Itaponse was
lower during combined dipyridamole-dobutnmine tests than
during dobutamine alone but did not reach statistical signif-
icance. That pattern was consistently observed even when
eehocardiogaphicahly or angiogaphically, or both, positive
eases versus negative cases were analysed .
Diepmde stoma y d dilitysl adolmaaine echoor•
d ap . . lesthng far roraoary artery disease. The overall
sensitivity of the dipyridamdedobutamine echocardio-
graphic teal for coronary artery disease was 92% (95% C1
87% to 98%. (p < 0.01 vs. dipyridamole and vs . dobutamine)
IFIg, 2) . The overall specificity of the dipyridamole-
dobotamine echocardiographic test for coronary artery dis-
ease was 19% (95% CI
76% to 100%) (P - NS vs . dipyri-
damde and vs. dabutamine) (Fig . 3). The addition of
dobutamim to dipyridamole raised the sensitivity of the test
from 71% to 91%. with no loss in specificity, by identifying
an additional 27 patients
with
coronary artery disease .
Although the sensitivity of the combined lost was 9246, the
sensitivity ofdipyridamole-dobmamine echocardiography in
the Mats of 55 patients was actually 71% (27 positive tests
in 38 patients with coronary artery disease), whereas the
specificity wait LOD% 417 of 17 true negative
ratings). In 14
of 27 patier:s with echocardiogmphic positivity
. the
dipyridamole-Ifobutamine tat wait accompanied by chest
pain, and in 14 patients significant ST segment depression
also occurred . Of the 28 negative dipyridamole-debutamine
tests by echtscsrdiographic criteria, chat pain was present in
eight patients, and significant ST segment changes were
noted in one patient. In 7 patients with and 31 patients
without real wall motion abnormalities, we found no differ-
ence (p = NS) with regard to the sensitivity of dipyridamole
dobatamine echocardiography to detect myocardial isch-
emia: 5 (71%) of 7 patients with rest wall motion
abnormalities had a positive dipyridamole-dobulamiec
echoeasdioge
.phic test, and 22 (71%) of 31 patients wish
OSTollc ET AI- .
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Table 3 . Disnibudon of
Stress Echpcardivara bic Results Related
to Coronary Arte3Iographic Findings
Low DET
. . Jip eidaook wMurdiatpaphic test pas ire alter the low
dose i9
% mote for 4 tun): high DET+ = dipyddanole who diographie
ten pouli+e after the Urea dose (0.84 enS%g fit 10 mis)
:
DIPDOa+ (-) =
poeitive 4negatisel dipytidueole .dol,utanine echocardiographic test ;
OOaET+1-I - posidse Isegmive)dobdaahreed,ocardiog∎aphic tat
: pis =
P.,-',
normal rest wall motion had a positive dipyridamole-
dobutemine echocardiegraphic test . In 27 patients with a
positive dipyridamole-dobummine test, the wall motion
score index went from 1
.04 ± 0.12 at baseline to 1 .31 ± 0.11
at peak dipyrdanole-dobutamine testing
(p < 0.01). A
positive result to the dipyridamole-dobutmmine test occurred
in 2 patients -.Met the first dobmamine dose (5 A8/k8 per
min). in'- patients after the second dose (10
Yglkg
per mitt).
in 9 patients after the third dose (20 *kg per min), in
2 patients after the fourth dose (30 pg/kg per min) and in
12 patients after the last dose (40 µglkg per min)
.
Test results related to coronary arteringraphic Oadiega .
There was a clear-ad tendency of a positive low dose
dipyridamole stress test to detect
patients with the most
severe coronary artery disease, whereas negative dipyrida-
mule-dobutarnine cehocardiography identified most accu-
rately patients without significant coronary artery disease
(p < D
.05) (Table 3) .
When only the patients whh single-vessel disease were
considered, the values of percent diameter slenosis tended
to be worse in the 79 patients with a positive dipyridamole
echocardiographic test (68.1 a: 9 .fi%) compared with the 25
patients with a positive dipyridamoledobmamine echocar-
diographic test (6(9 ± 13.1%). The values were lowest in
patients with a negative dipyridamolc-dobutamine echocar-
diographic test (62 .3 ± 7.4%, p = NS for all intergroup
differences)
. A similar trend was found for minimal lumen
diameter, which was 0.98 ± 0 .3 mm in patients with a
positive dipyridamole echocardiographic test, 0 .88'_ 0 .4 mm
in patients with a positive dipyridamok-dobutamine echocar-
diogmphic test and 1 .11 ± 0.24 men in pn ' :nts with a negative
dipyridamale-dobummine echocardiographic test (p = 0 .074
for all intergroup differences) .
Discussion
According to this initial experienc-, the dipyridamole
dobutamine echocatdiographic test is feasible and safe
. with
high diagnostic accuracy for the detection of angiographi-
No
. ofresseh a&cied 9 1 3
No. orpts 19 Its 10 6
Law DET+ h 27 3 3
HO DEr :
a 3 3
swoon.
5 n o
00PDOa- 17 11 0 a
DORET+ 4 85 8 5
DOtIT- Is 30 1
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tally assessed coronary artery disease even in patients with
relatively minor forms of coronary artery disease, as shown
by the negative results of the dipyridamole echocardio-
graphic test.
Patkogenetk meckanlsme of lachemfe daring dip)Tidamde •
dobuts mine tesing . Tests exploring organic coronary steno-
sis can induce isehemia through two basic mechanisms : I) an
increase in oxygen demand, exceeding the fixed supply ; and
2) How maldistrihution due to inappropriate coronary arte-
riolar vesodilation triggered by a metabolic or pharmsco-
logic, or both, stimulus (13). These two pathways can be
safely and effectively combined in a single test, as shown by
the accuracy or the dipyridamole exercise stress test to
detect milder forms of coronary artery disease (16)
.
After
dipyridamole administration, a alight increase in myocardial
function, a modest decrease in blood pressure and mild
taehycardia can be observed, globally determining only a
trivial increase in myocardial oxygen demand . Dipyridamole
provokes ischemia mainly through flow maldistrlbution phe-
nomena, ultimately determining a decrease in absolute sob
endocardial flow (17). The biochemical effector of this he-
modynamic mechanism is the inappropriate accumulation of
adenosine, which is the main physiologic modulator of
coronary arteriolar vasodilation because dipyridamole inhib-
its the cellular reuptake of endogenously produced ade-
noaine (1) . Dobutamine superimposes a marked inolropic
and chronotropic stress on dipyrid_.nole (whose effects last
>20 min after stopping the infusion), substantially increasing
myocardial oxygen demand . Furthermore, in a maximally
vasodilated bed, myocardial perfusion Is almost entirely
diastolic
(18)
; accordingly, the frequency Increase reduces
the perfusion time and may lead to a further reduction in
myocardial oxygen supply, especially in the aubendocardial
layer (19--21) .
Comparison with previous studies . Dipyridamole and
dabutnmlae stress accuracy
. As a by-product of its design
our study also allowed a direct comparison between dipyr-
idamole and dahutnmine echocardiographic tests, Several
reports have been published in this regard in bath the
experimental (22.23) and clinical (7.9-11) setting. In animal
experiments, a higher frequency of transient dyssynergy
with dobutamine than with dipyridamole (100% vs . 56%) was
reported. However, submaximal doses
of both dipyridamole
(0.56 mg/kg) and dobutamine (I5 pglkg per min for IS min)
were used In that study (22). When appropriately high doses
of dobutamine (40 pg/kg per min) and dipyridamole
(0.7 mg/kg) were used, a similar effect on regional left
ventricular function was detected (23). In the clinical setting,
there are three published reports on the direct comparison of
the two tests, all describing similar diagnostic accuracy
(7 .9,10) . When these studies are considered together
. there
is a trend toward a marginally superior sensitivity for dobu-
tembne (67% vs
. 59%, p = NS) and a marginally superior
specificity for dipyridamole (82% vs . 71%, p = NS)
. Our
results, in by far the largest patient group studied to date, are
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in agreement with these experimental and clinical data
because in the group that underwent both tests separately,
diagnostic accuracy was similar (24), although dipyridamole
tended to
have a slightly higher specificity and slightly lower
sensitivity . The moderate sensitivity of the two tests should
be considered in light of our study patients, most of whom
had single-vessel disease and in whom the sensitivity of
these tests was lower compared with pa ients with multives.
sel disease (2,9), who were studied while receiving antiamgi-
sal therapy (which further lowers the sensitivity of both
dipyridamole and dobutamine echocardiography) (8,12) .
Furthermore, our results are also consistent with those of
Marwick et al . (25) who found that high dose adenosine had
a similar specificity to dobutamine echocardiography, with a
lower sensitivity in single-vessel coronary artery disease .
However, up to 25% of patients could not tolerate maximal
adenosine doses, and this may well explain the sensitivity
gap because dipyridamole is much better tolerated than
adenosine.
Safety and effectiveness ofeamblined testing. It has been
shown in > 10,660 dipyridamole cchocmdiopsphic tests that
nearly all serious side effects occur within 10 min of the
test (26) . This led us to presume that immediate dobutamine
infusion after a negative full-dose dipyridamole test would
be safe. In our study, we did not observe either major
side effects or prolonged, antidote-resistant ischemia after
dipyridamole.dobutamine costing. This may be
due
to the
fact that all patients receiving ddwtamine had already had a
negative result with dipyeidamole alone, and most of them
also had a negative result with dottutamine alone, and
therefore more severe, extensive or hemodynamically ins.
pmtant degrees of coronary disease had been ruled out
.
Several modified protocols of dipyridamole eclmcardio-
graphic costs have been proposed to increase the pharmaco
logic stress eehoeardiography sensitivity, including handgrip
(27.28). dynamic exercise (16). tmnseaophageal pacing (29)
and atropine (30) in addition to dipyridasnole infusion . The
dipyridensck-dobmamine tchocardiographic lost has some
advantages over other combined approaches that have been
proposed to Increase dipyridamole echocardiographie test
sensitivity: It is not dependent on physical effort, as in the
combined dipyridanwlcexerclse test; it is mom sensitive
than the dipyridamole-handgrip test; and h is totally nonio-
vasive, unlike the dipyridamole-transesophogeal pacing test .
However, compared with the dipyridamoleetropine test, it
more frequently induced limiting side effects, mad the echo-
cardiography image quality was somewhat lowered by the
greater inotropic and tachycardlac effect of dobtttamine
.
Furthermore, imaging time is substantially longer with the
dipyridansole-dahutamine test than with the dipyridamole
atropine test . These relative disadvantages should be
weighed against the capability of the dipyridamole-
dohutamine test to generate even stronger ischemic stress to
the myocardium, as reflected by the excellent sensitivity
achieved in patients with negative results on conventional
stress tests and minor forms of coronary artery disease, as
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well as by the greater increase in heart rate and blood
pressure observed alter the dipyridamcle-dobutamine lest
compared with the dipyridamole-atropine test .
Study imWUoas. Our patients were studied en a consec-
utive basis, but it should be pointed out that Belgrade
University Institute for Cardiovascular Disease is a tertiary
care referral center for coronary angioplasty . This may well
explain the unusually high percent of patients with single-
vessel disease .
Almost 90% of the patients were receiving antianginal
therapy a the time of testing, and 47% received beta-
adrenergic blocking agents. It is well known that the sensi-
tivily of
both dobutamine (31) and dipyridamole 1121 echu-
cardiography decreases significantly when the tests ate
performed during medical therapy. One may therefore hy-
pothesize that after interruption of treatment (usually feasi-
ble bug often impractical in patients in stable condition
referred for diagnostic evaluation, as were
those described in
this study). the sensitivity
of
both
dipyridamule and dobu-
tamine alone would have been similar to that of the com-
bined test during medical therapy. Thus, the adjunctive
diagnostic value and the
clinical
role of ibis new test would
love been better assessed in a group
of patients not receiving
medical therapy .
The presence
of
medical therapy also
certainly contributed to obscure line correlation between
coronary sleaosis severity and stress test results in patients
with single-vessel disease.
Another limitation is that we used conventional high dose
regimens far dipyridamole (up to 0.81 mglkg) and dobu-
tamina (up 1040 rtglltg per min). For both tests, this infusion
protocol cannot be considered truly state of
the an because
it was recently shown that atropine (up to
I mg for 4 min)
addition further increases test sensitivity
without decreasing
specificity for both dohulantine (g) and dipyridamole (301
echocardogaghy.
Finally. although the test proved safe and feasible, its
completion in the case of a negative study takes at least
27
min .
whleh is relatively time-consuming for both the
physician and technician Involved in performing the study
and has the potential to adversely affect patient tolerance .
C11ieal hupHeatlmu. Efficacy, tolerability and ease of
execution make dobwamme a suitable pharmacologic coon
panion of dipyridamole stress testing when dyssynetgy, and
therefore isthemia . Is the diagnostic end point . It is equally
obvious, however, that large-scale experience at this point is
needed because initial feasibility studies an a new
lest slheuld
not be inappropriately viewed
as a validation, and, according
to Diamond (32), them is a big
difference between the seed of
efficacy and the fruit of
effectiveness. It is attractive to
propose dobutamine addition, in
a scalar stepwise fashion, in
all patients with a high dose dipyridamole test that continues
to be negative, so as to increase the sensitivity of !he test
with no loss in specifidty and only a moderate prolongation
of imaging time . Although the diagnostic domain of
the
dipyridamole dobummin
echocadographic test remains
=clear, its advantages might make it a very attractive
choice in patients with clinically suspected ischemic heart
disease and negative results on conventional stress test
procedures.
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